🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this study is to evaluate the effect of brensocati...
Status
Completed
Location
USA013
Start Date
2020-12-01
Trial ID
NCT04594369
Treatments Being Tested
The primary purpose of this study is to determine the relative bioavailabil...
Status
Completed
Location
USA001
Start Date
2024-04-30
Trial ID
NCT06344728
Treatments Being Tested
The primary purpose of this study is to determine the effect of clarithromy...
Status
Completed
Location
USA001
Start Date
2023-07-28
Trial ID
NCT05965570
Treatments Being Tested
The primary purpose of this study is to assess the effects of rifampin on t...
Status
Completed
Location
USA001
Start Date
2023-05-10
Trial ID
NCT05826574
Treatments Being Tested
The primary purpose of the study is to evaluate the efficacy of brensocatib...
Status
Completed
Location
USA034
Start Date
2023-10-30
Trial ID
NCT06013241
Treatments Being Tested
The primary purpose of Part A of this study is to compare, in a single dose...
Status
Completed
Location
USA001
Start Date
2019-01-09
Trial ID
NCT05927597
The primary purpose of the study is to evaluate the effect of brensocatib c...
Status
Terminated
Location
USA001
Start Date
2024-12-16
Trial ID
NCT06685835
Treatments Being Tested
The purpose of the study is to evaluate if INS1007 can reduce pulmonary exa...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2017-10-31
Trial ID
NCT03218917
Treatments Being Tested
The primary purpose of this study is to assess the palatability and compare...
Status
Completed
Location
USA001
Start Date
2023-12-27
Trial ID
NCT06178783
Treatments Being Tested
The primary purpose of the study is to determine the pharmacokinetics (PK) ...
Status
Completed
Location
USA002
Start Date
2021-07-20
Trial ID
NCT05673603
Treatments Being Tested